Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Scholar Rock (SRRK.US)$ breakthrough in spinal muscular the...

$Scholar Rock(SRRK.US)$ breakthrough in spinal muscular therapy has skyrocketed with projection of $27-52 target range.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
1
Translate
Report
14K Views
Comment
Sign in to post a comment
  • Gilley : dude they're price over is over a top pharmaceutical companys that actually makes profit and has drugs on the market this company has neither they make no money their financials or garbage this has no reason to be this high besides for this giant offering about to come out I'm sure they're going to have one a week now they got too many shares to hand out this is just beyond a little overpriced it's three times it's freaking book value like double is pretty crazy to just think for future aspects of the company especially knowing there's top pharmaceutical companies out there that actually make steady profit ever year and this hasn't made any profit since it started let alone has any drugs in the market any price above 20 is crazy high

17Followers
5Following
28Visitors
Follow